Inventor · disambiguated record
Keith Elkon
Also filed as: ELKON KEITH · ELKON KEITH B
15 granted patents·7 pending applications·173 citations·filing 1986–2022
93Inventor score
Files withUNIV WASHINGTON9LEDBETTER JEFFREY A3ZYMOGENETICS INC3COMMERCIALIZATION UNIVERSITY OF WA CT FOR1CORNELL RES FOUNDATION INC1
Top patents by PatentIndex Score
22 records- 0197US11306297B2Therapeutic nuclease compositions and methodsUNIV WASHINGTON·Filed 2017·Granted Apr 19, 2022·7 cites·28 claims
- 0296US8841416B2Therapeutic nuclease compositions and methodsLEDBETTER JEFFREY A·Filed 2011·Granted Sep 23, 2014·34 cites·118 claims
- 0395US8937157B2Therapeutic nuclease compositions and methodsUNIV WASHINGTON·Filed 2014·Granted Jan 20, 2015·24 cites·39 claims
- 0494US10000745B2Therapeutic nuclease compositions and methodsUNIV WASHINGTON·Filed 2015·Granted Jun 19, 2018·12 cites·22 claims
- 0591US9790479B2Therapeutic nuclease compositions and methodsUNIV WASHINGTON·Filed 2014·Granted Oct 17, 2017·9 cites·84 claims
- 0690US10202588B2Therapeutic nuclease compositions and methodsLEDBETTER JEFFREY A·Filed 2012·Granted Feb 12, 2019·9 cites·84 claims
- 0790US9725506B2Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosusZYMOGENETICS INC·Filed 2014·Granted Aug 8, 2017·11 cites·4 claims
- 0889US11034944B2Therapeutic nuclease compositions and methodsUNIV WASHINGTON·Filed 2018·Granted Jun 15, 2021·4 cites·30 claims
- 0982US12435322B2Therapeutic nuclease compositions and methodsUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2022·Granted Oct 7, 2025·0 cites·22 claims
- 1082US8632773B2Antibody composition with altered Fab sialylationKAESERMANN FABIAN·Filed 2010·Granted Jan 21, 2014·20 cites·6 claims
- 1179US12338466B2Therapeutic nuclease compositions and methodsUNIV WASHINGTON·Filed 2021·Granted Jun 24, 2025·0 cites·30 claims
- 1271USRE48370ELevels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosusZYMOGENETICS INC·Filed 2018·Granted Dec 29, 2020·0 cites·6 claims
- 1368US4865970AMethod of detecting ribosomal protein antibodies in systemic lupus erythematosusHOFFMANN LA ROCHE·Filed 1986·Granted Sep 12, 1989·30 cites·7 claims
- 1467US2014227269A1Therapeutic nuclease compositions and methodsUNIV WASHINGTON·Filed 2014·Application pending·0 cites
- 1567US2009325196A1Levels of bcma protein expression on b cells and use in diagnostic methodsZYMOGENETICS INC·Filed 2009·Application pending·0 cites
- 1664US2013183308A1Therapeutic nuclease compositions and methodsCOMMERCIALIZATION UNIVERSITY OF WA CT FOR·Filed 2013·Application pending·0 cites
- 1764US2013184334A1Therapeutic nuclease compositions and methodsUNIV WA CT FOR COMMERCIALIZATION·Filed 2013·Application pending·0 cites
- 1864US2013177561A1Therapeutic nuclease compositions and methodsUW CT FOR COMMERCIALIZATION·Filed 2013·Application pending·0 cites
- 1959US6525029B1Method of inhibiting and immune response to a recombinant vectorCORNELL RES FOUNDATION INC·Filed 1998·Granted Feb 25, 2003·13 cites·6 claims
- 2059US2013089546A1Therapeutic nuclease compositions and methodsLEDBETTER JEFFREY A·Filed 2010·Application pending·0 cites
- 2146US2021215692A1Compositions and methods for treating inflammatory diseasesUNIV WASHINGTON·Filed 2019·Application pending·0 cites
- 2239US10329258B2CGAS in systemic lupus erythematosus (SLE)UNIV WASHINGTON·Filed 2016·Granted Jun 25, 2019·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Keith Elkon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →